Solutions for Healthcare Providers

iStent infinite®

Can be Used in Patients Undergoing Cataract Surgery or a Standalone Procedure

The iStent infinite, is intended to reduce intraocular pressure safely and effectively in adult patients diagnosed with primary open-angle glaucoma, pseudo-exfoliative glaucoma or pigmentary glaucoma.

The device is safe and effective when implanted in combination with or without cataract surgery in those subjects who require intraocular pressure reduction and/or would benefit from glaucoma medication reduction.

The device may also be implanted in patients who continue to have elevated intraocular pressure despite prior treatment with glaucoma medications and/or conventional glaucoma surgery.

Learn more about studies

The Beginning of the Interventional Glaucoma Revolution

With 3 anatomically designed stents preloaded into an elegant injector system, iStent infinite® is a first-of-its-kind, standalone implantable alternative designed to:

  • Provide powerful technology to deliver foundational, 24/7, long-term control of IOP in patients with glaucoma
  • Safely offer interventional glaucoma, a truly micro-invasive alternative to medications and more invasive procedures, helping address rampant rates of patient non-compliance and disease progression
  • Restore physiologic outflow by creating arcs of flow spanning up to 8 clock hours (240°) while minimizing tissue disruption—broad coverage vs other MIGS procedures1
  • Provide you the versatility to treat a variety of patients

Illustration is not representative of actual anatomical structures.

Go With the Flow—Rejuvenate the System

Illustration is not representative of actual anatomical structures.

iStent infinite® is designed to maximize outflow while minimizing disruption to natural anatomy by occupying only 3% of Schlemm’s canal, thereby leaving 97% untouched.

This, coupled with a patented multidirectional stent design, helps bypass resistance and restore physiologic outflow.

Illustration is not representative of actual anatomical structures.

Intermediate Therapy That Excels Where Other Treatments Have Failed

In the prospective, multicenter, 12-month pivotal trial, patients with open-angle glaucoma who had failed prior surgical intervention underwent standalone iStent infinite® implantation1.

Despite this tough-to-treat population, iStent infinite® delivered exceptional results demonstrating sustained efficacy throughout the course of the study, as well as exceptional intraoperative and postoperative safety1.

View Clinical Data

 

Elegantly Precise Microsurgery

An elegant, precision-engineered injector system allows you to implant 3 wide-flange, anatomically designed stents across 180° of Schlemm’s canal.

Key Advantages to Using Glaukos Trabecular Micro-Bypass Device During Cataract Surgery Include:

Optimized Outflow

Three multidirectional stents designed to restore natural outflow

Clinically Proven

Significant IOP reduction across a wide range of clinical studies

Procedural Elegance

Predictability and precision meet the needs of your practice

Proven Safety

Safety profile similar to cataract surgery alone

All With the Exceptional Customer Support You’ve Come to Expect From Glaukos

Explore Patient Resources for Glaucoma
Treatment Options

iStent infinite® is indicated for use in adult patients with primary open-angle glaucoma in whom previous medical and surgical treatment has failed. Through this procedure, you may be able to provide your patients with better IOP control and a reduced dependence on medication.

View Patient Website

Complete the form to get started with offering iStent infinite® to your patients.

Request More Info

"*" indicates required fields

Address*
This field is for validation purposes and should be left unchanged.

Reference

  • Glaukos Data on File.

Please Select Your Country

Continue